Concentra Group Holdings Parent Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Concentra Group Holdings Parent Inc 's ROA in the third quarter of 2026?
Concentra Group Holdings Parent Inc achieved a return on average assets (ROA) of 7.53 % in its third quarter of 2026, this is above CON's average return on assets of 6.41%.
Concentra Group Holdings Parent Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion

Despite the company's net income deteriorating, Concentra Group Holdings Parent Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 124 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 969, from total ROA ranking in the second quarter of 2026 at 1177.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	5.9 %	5.94 %	5.88 %	12.77 %	14.63 %
Y / Y Net Income Change	32.24 %	45.69 %	28.66 %	58.73 %	8.88 %
Net Income (TTM) in million	222	206	184	173	159
Return On Assets (TTM)	7.53 %	7.09 %	6.45 %	6.13 %	5.83 %
CON's Total Ranking	# 969	# 1177	# 1058	# 1040	# 978
Total Assets (TTM) in million	3,012	3,010	2,890	2,858	2,844
Seq. Total Assets Change	0.05 %	4.17 %	1.1 %	0.51 %	0.08 %
Seq. Net Income Change	-2.1 %	28.7 %	44.49 %	-27.36 %	7.85 %

CON's 5 Years Annual ROA >> Back to CON Management Effectiveness >> Compare CON ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 125
Overall	# 881

Return On Assets Statistics
High	Average	Low
7.09 %	6.41 %	5.83 %
(Jun 30 2026)		(Sep 30 2025)

Financial Statements
Concentra Group Holdings Parent Inc 's Assets	$ 3,012 million	CON's Balance sheet
Concentra Group Holdings Parent Inc 's Income	$ 66 million	Quarterly CON's Income Statement
CON's Income by Division		See CON's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	13.38 %	-	-	-	-
Total Assets in million	2,858	2,521	0	0	0
Y / Y Net Income Change	0.55 %	-	-	-	-
Net Income in million	173	172	0	0	0
Annual Return On Assets	6.05 %	6.82 %	-	-	-

CON's 5 Years Annual ROA >> Back to CON Management Effectiveness >> Compare CON ROA to its Competitors

Comment on CON's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 6.05 %, despite annual net income growth of 0.55 % to $172.85 million, from $171.90 million a year ago, as CON's assets increase to $2,858.39 million, by 0.55 %.

More Return On Assets Ratios
CON's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CON's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CON's Competitors
Subscribers only: Roa for Concentra Group Holdings Parent Inc 's Suppliers
Subscribers only: Return On Assets for CON's Customers

You may also want to know
CON's Roi	CON's Inventory Turnover Ratio	CON's Growth Rates	CON's Dividend Comparisons
	CON's Profitability Ratios	CON's Asset Turnover Ratio	CON's Dividend Growth
CON's Roe	CON's Valuation Ratios	CON's Financial Strength Ratios	CON's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %

Date modified: 2026-11-08T13:46:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.